l9n/ Pennsylvania

2021–2022 Regular Session

House Bill 1741

An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.

Did not become law. It stopped in the House of Representatives's Appropriations Committee on June 14, 2022. The 2021–2022 session has ended.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

Its course

July 30, 2021 to June 14, 2022, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action10 actions on 5 days

In the House of RepresentativesJul 30 to Jun 14 · stopped319 days

HealthJul 30 to Feb 7192 days

AppropriationsJun 14 to Jun 14 · stopped0 days

Amendments

Each amendment offered, and what became of it.

  • House of Representatives committee amendmentAdopted

    Adopted Feb 7, 2022

  • House of Representatives floor amendmentAdopted

    Adopted Jun 14, 2022

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the House of Representatives Jul 30 – Jun 14, 2022

  1. Sent to HEALTH
  2. HEALTH recommended it as amended
  3. Amended and read a second time
  4. Sent to APPROPRIATIONS
All 10 actions, as published